SCHEMBL20097401

SCHEMBL20097401

CCc1cc(Br)cc(CN2CCN(C)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 5/20 0.49
MAPT P10636 3/20 0.49
MC4R P32245 1/20 0.49
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 1/20 0.46
POLB P06746 1/20 0.46
CHKA P35790 3/20 0.44
TDP1 Q9NUW8 2/20 0.42
DDR1 Q08345 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
CA2 P00918 1/20 0.41
NCF1 P14598 1/20 0.41
PRMT6 Q96LA8 1/20 0.41
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18626505 0.83 ALDH1A1 (0.49) KDM4EALDH1A1MAPTMC4RLMNA
SCHEMBL14791995 0.81 ALDH1A1 (0.47) KDM4EALDH1A1MAPTMC4RLMNA
SCHEMBL2935699 0.79 GAA (0.52) KDM4EALDH1A1MAPTMC4RLMNA
SCHEMBL9610929 0.79 ALDH1A1 (0.45) KDM4EALDH1A1MAPTMC4RLMNA
SCHEMBL9610928 0.78 ALDH1A1 (0.44) KDM4EALDH1A1MAPTMC4RLMNA
SCHEMBL12830614 0.77 MC4R (0.65) KDM4EALDH1A1MC4RLMNACHKA
SCHEMBL1367503 0.76 SMN1; SMN2 (0.70) KDM4EMC4RLMNASMN1; SMN2POLB
SCHEMBL306744 0.76 LMNA (0.69) KDM4EALDH1A1MC4RLMNASMN1; SMN2
SCHEMBL14228427 0.75 HRH3 (0.54) KDM4EALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL112800 0.75 MC4R (0.47) KDM4EALDH1A1MAPTMC4RLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018075858-A1 METHODS OF USING INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/B-CATENIN SIGNALING PATHWAY INHIBITORS SAMUMED, LLC (US) 2018-04-26 WO disclosed